Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000430.4(PAFAH1B1):c.1159+2T>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
PAFAH1B1 (HGNC:8574): (platelet activating factor acetylhydrolase 1b regulatory subunit 1) This locus was identified as encoding a gene that when mutated or lost caused the lissencephaly associated with Miller-Dieker lissencephaly syndrome. This gene encodes the non-catalytic alpha subunit of the intracellular Ib isoform of platelet-activating factor acteylhydrolase, a heterotrimeric enzyme that specifically catalyzes the removal of the acetyl group at the SN-2 position of platelet-activating factor (identified as 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine). Two other isoforms of intracellular platelet-activating factor acetylhydrolase exist: one composed of multiple subunits, the other, a single subunit. In addition, a single-subunit isoform of this enzyme is found in serum. [provided by RefSeq, Apr 2009]
Our verdict: Pathogenic. The variant received 18 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 4.5, offset of 4, new splice context is: aatGTacgc. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-2680322-T-A is Pathogenic according to our data. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-2680322-T-A is described in CliVar as Pathogenic. Clinvar id is 159496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Genetic Services Laboratory, University of Chicago
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not providedPathogenic:1
Jul 14, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PAFAH1B1 protein in which other variant(s) (p.His389Tyr) have been determined to be pathogenic (PMID: 19808989). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 159496). This variant has not been reported in the literature in individuals affected with PAFAH1B1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 10 of the PAFAH1B1 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. -